scholarly journals Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients☆

2009 ◽  
Vol 36 (4) ◽  
pp. 611-615 ◽  
Author(s):  
Umberto Benedetto ◽  
Giovanni Melina ◽  
Emiliano Angeloni ◽  
Simone Refice ◽  
Antonino Roscitano ◽  
...  
2008 ◽  
Vol 358 (4) ◽  
pp. 331-341 ◽  
Author(s):  
Edward L. Hannan ◽  
Chuntao Wu ◽  
Gary Walford ◽  
Alfred T. Culliford ◽  
Jeffrey P. Gold ◽  
...  

2007 ◽  
Vol 125 (4) ◽  
pp. 242-245 ◽  
Author(s):  
Hernani Pinto de Lemos Júnior ◽  
Álvaro Nagib Atallah

CONTEXT AND OBJECTIVE: The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need for coronary-artery bypass grafting. METHODS: This was a systematic review of the literature using the methodology of the Cochrane Collaboration. The type of study considered was controlled randomized trials; the type of intervention was drug-eluting or bare-metal stents; and the main outcome investigated was coronary-artery bypass grafting. RESULTS: The ten studies included in this systematic review did not show any statistically significant difference between the drug-eluting stents and the bare-metal stents with regard to the outcome of coronary-artery bypass grafting (confidence interval: 0.31 to 1.42). CONCLUSION: The surgical revascularization rate was not reduced by the use of drug-eluting stents.


Sign in / Sign up

Export Citation Format

Share Document